Serum antinuclear antibodies associate with worse prognosis in AQP4‐positive neuromyelitis optica spectrum disorder

Serum antinuclear antibodies associate with worse prognosis in AQP4‐positive neuromyelitis optica spectrum disorder

Abstract Background Studies have demonstrated that antinuclear antibodies (ANAs) may be correlated with neuromyelitis optica spectrum disorder (NMOSD). However, the conflicting results of studies about the value of ANAs in AQP4 antibody‐positive NMOSD patients need to be further investigated. Materi...

Full description

Bibliographic Details
Main Authors: Rong Fan, Yuefeng Zhang, Yunqi Xu, Jiayi Tong, Zhigang Chen, Meifeng Gu, Wenkui Fan, Yong Chen, Fuhua Peng, Ying Jiang
Format: Article
Language:English
Published: Wiley 2021-01-01
Series:Brain and Behavior
Subjects:
antinuclear antibody
neuromyelitis optica spectrum disorder
prognosis
Online Access:https://doi.org/10.1002/brb3.1865

Internet

https://doi.org/10.1002/brb3.1865

Similar Items